[46] have demonstrated that treatment of T2DM patients with acarbose for 12 weeks improves both hypoadiponectinemia and hyperglycemia, showing an increase in serum adiponectin level and a decrease in HbA1c% in blood. Here, ADIPOQ is linked to adiponectin deficiency.